Prøve GULL - Gratis
Cafeteria Diet - One of the prominent reasons behind stroke in India
Bio Spectrum
|December 2016
In the recently concluded 10th World Stroke Congress 2016 at Hyderabad, jointly organised by World Stroke Organisation (WSO) and Indian Stroke Association & Medtronic Inc., medical practitioners announced the launch of Stroke Roadmap in India. Currently, stroke incidence in India is much higher than western industrialised countries. With a population of 1.2 billion today and growing, India finds itself staring at a stroke epidemic.
The officials claim that the newly designed roadmap is intended to guide local healthcare officials and stroke care clinical groups in establishing stroke systems of care and will provide the framework for the implementation, monitoring and evaluation of stroke services nationally. In an exclusive interaction with BioSpectrum, Dr Jeyaraj Durai Pandian, Head of Neurology, Christian Medical College and Hospital, Ludhiana elaborates on the subject, and how the Stroke Roadmap might prove a perfect shield to dodge the disease.

Dr. Jeyaraj Durai Pandia
Head of Neurology, Christian Medical College and Hospital, ludhiana
Q: Why is the stroke rate climbing in India, specifically among the young generations?
A: 1.8 million Indians out of a population of 1.2 billion suffer from stroke every year. Common risk factors such as hypertension, diabetes, smoking, and dyslipidaemia are prevalent and insufficiently controlled due to low awareness levels of the disease. One of the primary factors of early stroke is the so-called ‘cafeteria diet’ which is rich in high-calorie, high-sugar and high-salt foods. Smoking and uncontrolled alcohol consumption also serve to exacerbate the situation.
The rising incidence of stroke in India indicates the inadequate levels of awareness and education about the disease. A stroke can strike anyone, at any time. Stroke rates among young and middle-aged people nationwide are increasing, almost 15 to 20 percent of strokes occur in people in their 30s and 40s.
Q: What is the general perception of the denizens of the country regarding stroke?
A: Surveys conducted over the last ten years reveal that about one-fourth of urban and one-third of rural respondents had no knowledge of any warning symptoms of stroke. Only 55 percent of the urban population were aware of one warning symptom of stroke; 16.2 percent were aware of two symptoms; and only 6.2 per cent could identify three symptoms.
Denne historien er fra December 2016-utgaven av Bio Spectrum.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum
WHO certifies Suriname malaria-free
Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).
1 min
August 2025

Bio Spectrum
Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation
Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.
1 min
August 2025
Bio Spectrum
Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab
Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.
1 min
August 2025
Bio Spectrum
Illumina buys SomaLogic for $425 M to accelerate proteomics business
Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.
1 min
August 2025

Bio Spectrum
Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26
Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.
1 min
August 2025
Bio Spectrum
WHO highlights risks associated with use of semaglutide medicines
The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.
1 min
August 2025

Bio Spectrum
Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin
Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.
1 min
August 2025

Bio Spectrum
AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru
AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.
1 min
August 2025

Bio Spectrum
Novo Nordisk launches injectable Semaglutide for weight management in India
Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.
1 min
August 2025

Bio Spectrum
Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?
India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.
12 mins
August 2025
Translate
Change font size